JangoBio offers investors a unique opportunity to participate in next-generation treatments targeting major unmet medical needs in hormone replacement, hypogonadism, and age-related disease. These are large and growing markets where patients seek improved therapeutic options. Our approach is to develop cell therapies with the capacity to restore function to gonadal tissues and thereby restore balance to the reproductive hormonal system. Please contact us if you are interested to review our prospectus.
(password required ; contact us)